Back to search

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.

Data up to Jan 2025

Published1996
Citations176
References27

Total Citations Per Year

Abstract

References (27)

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1993 • 3,680 citations

A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types

1994 • 2,821 citations

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1995 • 2,000 citations

E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins

1992 • 1,552 citations

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

1994 • 860 citations

Regulation of p16CDKN2 Expression and Its Implications for Cell Immortalization and Senescence

1996 • 713 citations

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

1995 • 713 citations

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1995 • 620 citations

Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4

1995 • 382 citations

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

1995 • 316 citations

Allelotype of human bladder cancer.

1994 • 265 citations

Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

1994 • 231 citations

Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

1993 • 187 citations

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer

1995 • 178 citations

Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.

1995 • 160 citations

Evidence for two bladder cancer suppressor loci on human chromosome 9.

1993 • 143 citations

The reactivation of telomerase activity in cancer progression

1996 • 134 citations

Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.

1994 • 130 citations

Increased p16 levels correlate with pRb alterations in human urothelial cells.

1995 • 120 citations

Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.

1995 • 118 citations

Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.

1987 • 112 citations

Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?

1996 • 96 citations

Growth kinetics and differentiation in vitro of normal human uroepithelial cells on collagen gel substrates in defined medium

1987 • 88 citations

High Frequency of Chromosome 9p Allelic Loss and CDKN2 Tumor Suppressor Gene Alterations in Squamous Cell Carcinoma of the Bladder

1995 • 74 citations

The 9p21 region in bladder cancer cell lines: large homozygous deletions inactivate the CDKN2, CDKN2B and MTAP genes

1996 • 46 citations

Quantitative assessments of the cytotoxicity of bladder carcinogens towards cultured normal human uroepithelial cells

1986 • 14 citations

Immortalization of human uroepithelial cells by human papillomavirus 16 E6 or E7

1995 • 7 citations

Cited By (0)

No citing papers found in database

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16… (1996) – PubMed | Metascience Observatory Explorer